We are live on ! Find out more
REPL icon

Replimune Group

51 hedge funds and large institutions have $182M invested in Replimune Group in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.73% more ownership

Funds ownership: 56.82%57.55% (+0.73%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

6% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 17

6% less funds holding

Funds holding: 5451 (-3)

37% less capital invested

Capital invested by funds: $289M → $182M (-$107M)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
1.14%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
5
Increased
16
Reduced
17
Closed
8
Calls
Puts
Net Calls
Net Calls Change

REPL Hedge Fund Activity: Q4 2018 in Review

51 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2018, worth a combined $182M — down 37% from $289M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of REPL and 5 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 16 added.

The largest buyer was BlackRock, adding an estimated $4.3M. The largest seller was Citadel Advisors, cutting an estimated $2.12M.

  • 51 institutional investors held Replimune Group (REPL) as of Q4 2018, down from 54 in Q3 2018.
  • Funds reported $182M of Replimune Group stock for Q4 2018, down 37% quarter-over-quarter.
  • 5 funds opened new Replimune Group positions in Q4 2018 and 8 closed out, a net change of -3 holders.
  • The largest Replimune Group buyer in Q4 2018 was BlackRock, an estimated $4.3M added.
  • The largest Replimune Group seller in Q4 2018 was Citadel Advisors, an estimated $2.12M sold.

Based on aggregated 13F filings for Q4 2018.